Phenominer Database Results (36 results)

 

How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Clinical Measurement Notes Record ID Study ID
WAG/Nov G0 stage diploid thymocyte count to total thymocyte count ratio vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. T cell development trait male 150 days-180 days 10 93.31 % 0.93 2.94 flow cytometry method 0.0 IP injection 1 days saline 107709 3096
WAG/Nov CD4+CD8- thymocyte count vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 239.75 x 10E6/organ 50.38 159.32 flow cytometry method 0.0 IP injeciton 1 days saline cd4+cd8- t-cell 107718 3096
WAG/Nov CD4+CD8+ thymocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 512.96 x10E6/organ 161.9 511.97 flow cytometry method 0.0 0 cd4+cd8+ t-cell 107720 3096
WAG/Nov CD4+CD8+ thymocyte count lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 176.61 x10E6/organ 32.55 102.93 flow cytometry method 0.0 IP injection 1 days cd4+cd8+ t-cell 107722 3096
WAG/Nov CD4+CD25- splenocyte count to total splenocyte count ratio control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 25.7 % 1.16 3.67 flow cytometry method 0.0 0 cd4+cd25- spleen 107729 3096
WAG/Nov CD11b/c+ splenocyte count to total splenocyte count ratio control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 13.89 % 1.48 4.68 flow cytometry method 0.0 0 cd11b/c+ spleen 107735 3096
WAG/Nov CD4+CD8+ thymocyte count vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 596.53 x10E6/organ 88.59 280.15 flow cytometry method 0.0 IP injeciton 1 days saline cd4+cd8+ t-cell 107721 3096
WAG/Nov CD4-CD8+ thymocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 74.55 x10E6/organ 18.13 57.33 flow cytometry method 0.0 0 cd4-cd8+ t-cell 107723 3096
WAG/Nov CD4+CD25+ thymocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 39.38 x10E6/organ 6.0 18.97 flow cytometry method 0.0 0 cd4+cd25+ t-cell 107726 3096
WAG/Nov CD3+ splenocyte count to total splenocyte count ratio lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 23.34 % 2.11 6.67 flow cytometry method 0.0 IP injection 1 days cd3+ spleen 107734 3096
WAG/Nov CD11b/c+ splenocyte count vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 92.63 x10E6/organ 24.28 76.78 flow cytometry method 0.0 IP injeciton 1 days saline cd11b/c+ spleen 107739 3096
WAG/Nov CD11b/c+ splenocyte count lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 253.98 x10E6/organ 53.16 168.11 flow cytometry method 0.0 IP injection 1 days cd11b/c+ spleen 107740 3096
WAG/Nov CD4-CD8+ thymocyte count lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 29.08 x10E6/organ 4.63 14.64 flow cytometry method 0.0 IP injection 1 days cd4-cd8+ t-cell 107725 3096
WAG/Nov CD4+CD25+ thymocyte count vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 40.63 x10E6/organ 7.77 24.57 flow cytometry method 0.0 IP injeciton 1 days saline cd4+cd25+ t-cell 107727 3096
WAG/Nov CD4+CD25- splenocyte count to total splenocyte count ratio vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 27.9 % 0.69 2.18 flow cytometry method 0.0 IP injeciton 1 days saline cd4+cd25- spleen 107730 3096
WAG/Nov CD3+ splenocyte count to total splenocyte count ratio vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 30.13 % 0.75 2.37 flow cytometry method 0.0 IP injeciton 1 days saline cd3- spleen 107733 3096
WAG/Nov CD11b/c+ splenocyte count to total splenocyte count ratio vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 12.4 % 0.81 2.56 flow cytometry method 0.0 IP injeciton 1 days saline cd11b/c+ spleen 107736 3096
WAG/Nov CD11b/c+ splenocyte count to total splenocyte count ratio lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 19.14 % 1.71 5.41 flow cytometry method 0.0 IP injection 1 days cd11b/c+ spleen 107737 3096
WAG/Nov apoptotic hypodiploid thymocyte count to total thymocyte count ratio vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. T cell development trait male 150 days-180 days 10 0.45 % 0.12 0.38 flow cytometry method 0.0 IP injection 1 days saline 107706 3096
WAG/Nov apoptotic hypodiploid thymocyte count to total thymocyte count ratio lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. T cell development trait male 150 days-180 days 10 1.88 % 0.39 1.23 flow cytometry method 0.0 IP injection 1 days 107707 3096
WAG/Nov G0 stage diploid thymocyte count to total thymocyte count ratio lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. T cell development trait male 150 days-180 days 10 86.73 % 1.67 5.28 flow cytometry method 0.0 IP injection 1 days 107710 3096
WAG/Nov G2/M stage tetraploid thymocyte count to total thymocyte count ratio control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. T cell development trait male 150 days-180 days 10 3.13 % 0.46 1.45 flow cytometry method 0.0 0 107711 3096
WAG/Nov CD3+ thymocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 889.52 x10E6/organ 215.59 681.76 flow cytometry method 0.0 0 cd3+ thymocyte 107714 3096
WAG/Nov CD3+ thymocyte count vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 1021.26 x10E6/organ 145.57 460.33 flow cytometry method 0.0 IP injeciton 1 days saline cd3+ thymocyte 107715 3096
WAG/Nov CD4+CD8- thymocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 199.43 x 10E6/organ 33.75 106.73 flow cytometry method 0.0 0 cd4+cd8- t-cell 107717 3096
WAG/Nov CD3+ splenocyte count to total splenocyte count ratio control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 29.81 % 0.57 1.8 flow cytometry method 0.0 0 cd3+ spleen 107732 3096
WAG/Nov apoptotic hypodiploid thymocyte count to total thymocyte count ratio control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. T cell development trait male 150 days-180 days 10 0.34 % 0.09 0.28 flow cytometry method 0.0 0 107705 3096
WAG/Nov G0 stage diploid thymocyte count to total thymocyte count ratio control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. T cell development trait male 150 days-180 days 10 92.68 % 0.6 1.9 flow cytometry method 0.0 0 107708 3096
WAG/Nov G2/M stage tetraploid thymocyte count to total thymocyte count ratio vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. T cell development trait male 150 days-180 days 10 2.62 % 0.29 0.92 flow cytometry method 0.0 IP injeciton 1 days saline 107712 3096
WAG/Nov G2/M stage tetraploid thymocyte count to total thymocyte count ratio lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. T cell development trait male 150 days-180 days 10 6.34 % 1.27 4.02 flow cytometry method 0.0 IP injection 1 days 107713 3096
WAG/Nov CD3+ thymocyte count lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 376.49 x10E6/organ 64.81 204.95 flow cytometry method 0.0 IP injection 1 days cd3+ thymocyte 107716 3096
WAG/Nov CD4+CD8- thymocyte count lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 112.44 x 10E6/organ 24.64 77.92 flow cytometry method 0.0 IP injection 1 days cd4+cd8- t-cell 107719 3096
WAG/Nov CD4-CD8+ thymocyte count vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 74.18 x10E6/organ 11.97 37.85 flow cytometry method 0.0 IP injeciton 1 days saline cd4-cd8+ t-cell 107724 3096
WAG/Nov CD4+CD25+ thymocyte count lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 20.02 x10E6/organ 4.65 14.7 flow cytometry method 0.0 IP injection 1 days cd4+cd25+ t-cell 107728 3096
WAG/Nov CD4+CD25- splenocyte count to total splenocyte count ratio lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 25.17 % 0.78 2.47 flow cytometry method 0.0 IP injection 1 days cd4+cd25- spleen 107731 3096
WAG/Nov CD11b/c+ splenocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 86.13 x10E6/organ 25.02 79.12 flow cytometry method 0.0 0 cd11b/c+ spleen 107738 3096